Dyslipidemias in type II diabetes mellitus patients in a teaching hospital of Lahore, Pakistan

Pakistan Journal of Medical Sciences

Volumn 19, Issue 4, 2003, Pages 283-286

  Naheed, Talat ^a,c   Khan, Aamir ^b   Masood, Gulsena ^b   Yunus, Bilal Bin ^b   Chaudhry, M A ^b  

^a KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

^b FATIMA JINNAH MEDICAL COLLEGE   (Pakistan)

^c NONE   (Pakistan)

Author keywords

Cholesterol; Coronary Heart Disease (CHD); Diabetes Mellitus (DM); Dyslipidemias; HDL C; LDL C; Triglycerides

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIABETES CONTROL; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAKISTAN; SMOKING; TEACHING HOSPITAL;

EID: 0345730922     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Betteridge DJ. Diabetic dyslipidemia. Diabetes Obes Metab 2000; 2 Suppl 1: S31-6.
2. Henkel E, Hanefeld M. Hyperlipidemia and fibrates with special reference to diabetes. Herz 2001; 26(8): 523-30.
3. Ginsberg HN. Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease. Curr Cardiol Rep 1999; 1(3): 233-7.
4. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83(9B): 25F-29F.
5. Hashim R, Khan FA, Khan DA, Shaukat A. Prevalence of macrovascular complications in diabetics of Wah, District Rawalpindi. J Pak Med Assoc 1999; 49(1): 8-11.
6. Laakso M. Dyslipidemia, morbidity, and mortality in non-insulin depefidant diabetes mellitus. Lipoproteins and coronary heart disease in non-insulin dependant diabetes mellitus. J Diabetes Complications 1997; 11(2): 137-41.
7. Berra K. Women, coronary heart disease, and dyslipidemia: dose gender alter detection, evaluation, or therapy? J Cardiovasc Nurs 2000; 14(2):59-78.
8. U.K. Prospective Diabetes Study 27. Plasma Lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997; 20(11):1683-7.
9. Lewis SJ. Cholesterol and coronary heart disease in women. Cardiol Clin 1998; 16(1): 9-15.
10. King KB, Mosca L. Prevention of heart disease in women: recommendations for management of risk factors. Prog Cardiovasc Nurs 2000; 15(2): 36-42.
11. Brochier ML, Arwidson P. Coronary heart disease risk factors in women. Eur Heart J 1998; 19 Suppl A: A45-52.
12. Haffner SM, Miettinen H, Stern MP. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in pre-diabetic men. Diabetologia 1997; 40(6): 711-7.
13. Oh HS, Seo WS. Inter-relationships between arterisclerotic risk factors: a metab-analysis. Yonsei Med J 2000; 41(4): 450-8.
14. Lepsanovic L, Brkljac O, Lepsanovic L. Effect of smoking on lipoprotein metabolism. Med Preg 2001; 54(9-10): 453-8.
15. Aboola-Abu CF, Ohwovoriole AE, Akinlade KS. The effect of glycaemic control on the prevalence and pattern of dyslipidemia in Nigerian patients with newly diagnosed non-insulin dependent diabetes mellitus. West Afr J Med 2000; 19(1): 27-33.
16. Alagozlu H, Gultekin F, Candan F. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients Do LP(a) levels decrease with improved glycaemic control in these patients? Nutr Metab Cardiovasc Dis 2000; 10(4): 204-8.
17. Naheed T, Akbar N, Akbar N. Skin manifestation amongst diabetic patients admitted in general medical ward for various other problems. Pak J Med Sci 2002;18(4)291-296.